1. Scrip

Newly Launched Eir Ventures To Target ‘Early Nordic Opportunities’

Founders Plan To Invest In Region’s ‘Underappreciated’ Life Sciences

 
• By Sten Stovall

The Nordic region’s vibrant life sciences ecosystem will be the chief focus for newly created Eir Ventures, a strategic partnership and investment company.  

Scandinavia
Fund is equipped with initial €76m ($85m) for targeted investments • Source: Shutterstock

Nordic investment fund Eir Ventures has just launched, armed with €76m ($85m) that mangers say will be invested in innovative life science companies in the region to advance cutting-edge therapies and technologies there that might otherwise not get the attention they deserve. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Merck & Co. CMO Barr On Breaking Into Immunology And Ophthalmology

 
• By Jessica Merrill

Chief medical officer Eliav Barr discussed Merck’s investment in new therapeutic areas and business development in an interview with Scrip.

Zelluna Believes Its TCR Tech Can Unlock Natural Killer Cell Potential

 
• By Andrew McConaghie

While CAR-NKs have pivoted towards autoimmune disease, the Norwegian biotech believes its unique platform can deliver in oncology

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies